v3.25.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Summary of Significant Accounting Policies  
Schedule of potentially dilutive shares

Year Ended

Year Ended

December 31, 

December 31, 

    

2024

    

2023

(Restated)

Net loss

$

(57,702,015)

$

(3,762,930)

Weighted average shares outstanding – basic and diluted

10,213,036

9,998,446

Net loss per share – basic and diluted

$

(5.65)

$

(0.38)

Excluded securities (1):

Public Warrants

11,500,000

Private Warrants

557,000

Bridge Warrants

173,913

Extension Warrants

26,086

September 2024 Warrants

740,741

Quantum Convertible Note, related party (2)

1,862,466

Exchange Note (2)

827,330

September 2024 Convertible Note (3)

1,258,733

Series A Preferred Stock (4)

3,079,000

Stock options, issued and outstanding

803,646

Common stock issuance obligation

51,192

1.The Company’s dilutive shares have not been included in the computation of diluted net loss per share for the years ended December 31, 2024 and 2023, as the result would be anti-dilutive.
2.Includes the interest amount thereon and assumes the floor conversion price of $2.00.
3.Includes the principal and interest amount thereon and calculated based on the initial fixed conversion price of $2.00.
4.Assumes the maximum conversion thereon and at the floor conversion price of $2.00
Schedule of allowance for credit losses

    

December 31, 

    

December 31, 

2024

2023

Beginning allowance for credit losses

$

32,457

$

Allowance for credit losses, due to acquisition

 

1,696,553

 

Provision for credit losses

 

514,282

 

32,457

Less: Accounts receivable write-off included in allowance for credit losses above

 

149,741

 

Ending allowance for credit losses

$

2,393,033

$

32,457

Schedule of Identifiable intangible assets subject to amortization

December 31, 2024

Estimated Useful Life

Gross Carrying Amount

Additions

Accumulated Amortization

Net Book Value

Customer relationships

10 years

$-

$2,100,000

($105,000)

$1,995,000

Developed technology

5 years

 

10,000,000

(1,000,000)

9,000,000

$-

$12,100,000

($1,105,000)

$10,995,000

Schedule of expected amortization expense

Year ending December 31, 2025

    

$

2,210,000

Year ending December 31, 2026

 

2,210,000

Year ending December 31, 2027

 

2,210,000

Year ending December 31, 2028

 

2,210,000

Year ending December 31, 2029

 

2,155,000

Total

$

10,995,000